Gender-Affirming Hormone Therapy for Transgender Females

被引:34
|
作者
Randolph, John F., Jr. [1 ,2 ]
机构
[1] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Reprod Michigan Med, Ann Arbor, MI 48109 USA
来源
CLINICAL OBSTETRICS AND GYNECOLOGY | 2018年 / 61卷 / 04期
关键词
transgender females; gender-affirming; estrogen; antiandrogens; androgen blockers; hormone therapy; VENOUS THROMBOEMBOLISM; TRANSSEXUAL SUBJECTS; OPTIONS;
D O I
10.1097/GRF.0000000000000396
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The provision of hormone therapy, both estrogens and antiandrogens, to adult transgender females is well within the scope of practice of the obstetrician gynecologist. The goal is to induce feminizing changes and suppress previously developed masculinization. Estrogens in sufficient doses will usually achieve both goals with augmentation by antiandrogens. The primary short-term risk of estrogens is thrombosis, but long-term risk in transgender females is unclear. Optimal care requires pretreatment education and assessment, individualized dosing, ongoing routine monitoring, and standard breast and prostate cancer screening.
引用
收藏
页码:705 / 721
页数:17
相关论文
共 50 条
  • [1] Gender-Affirming Hormone Therapy for Transgender Men
    Moravek, Molly B.
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2018, 61 (04): : 687 - 704
  • [2] Cancer and gender-affirming hormone therapy in transgender individuals
    Cheung, Ada
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 86 - 86
  • [3] Gender-affirming hormone therapy and cardiovascular health in transgender adults
    Ong, Caroline
    Monita, Monique
    Liu, Minghao
    [J]. CLIMACTERIC, 2024, 27 (03) : 227 - 235
  • [4] Bone Density in Transgender Youth on Gender-Affirming Hormone Therapy
    Roy, Micaela K.
    Bothwell, Samantha
    Kelsey, Megan M.
    Ma, Nina S.
    Moreau, Kerrie L.
    Nadeau, Kristen J.
    Rothman, Micol S.
    Nokoff, Natalie J.
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (05)
  • [5] An introduction to gender-affirming hormone therapy for transgender and gender-nonbinary patients
    Harris, Miles S.
    Goodrum, Ashby
    Krempasky, Chance N.
    [J]. NURSE PRACTITIONER, 2022, 47 (03): : 18 - 28
  • [6] Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia
    Nolan, Brendan J.
    Cheung, Ada S.
    [J]. INTERNAL MEDICINE JOURNAL, 2024, 54 (09) : 1450 - 1457
  • [7] Gallbladder disease in transgender individuals: associations with gender-affirming hormone therapy
    Tabernacki, Tomasz
    Loria, Matthew
    Rhodes, Stephen
    Pope, Rachel
    Gupta, Shubham
    Banik, Swagata
    Mishra, Kirtishri
    [J]. INTERNATIONAL JOURNAL OF TRANSGENDER HEALTH, 2023,
  • [8] The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
    Yau, Mabel
    Safer, Joshua D.
    [J]. CELL REPORTS MEDICINE, 2023, 4 (01)
  • [9] Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents
    Millington, Kate
    Lee, Janet Y.
    Olson-Kennedy, Johanna
    Garofalo, Robert
    Rosenthal, Stephen M.
    Chan, Yee-Ming
    [J]. PEDIATRICS, 2024, 153 (05)
  • [10] Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy
    Mullins, Eric S.
    Geer, Rebecca
    Metcalf, Megan
    Piccola, Jeanne
    Lane, Adam
    Conard, Lee Ann E.
    Mullins, Tanya L. Kowalczyk
    [J]. PEDIATRICS, 2021, 147 (04)